There are two general types of endoscopic therapies available for the treatment of Barrett's
esophagus:(1) endoscopic ablative therapy, which uses thermal, photochemical, or …

Background: Management of high‐grade dysplasia in Barrett's oesophagus is controversial:
surgery carries an appreciable morbidity/mortality, high‐grade dysplasia may not progress …

Reports on the natural history of high‐grade dysplasia (HGD) are sometimes contradictory,
but suggest that 10–30% of patients with HGD in Barrett's esophagus (BE) will develop a …

The management of Barrett's oesophagus and associated neoplasia has evolved
considerably in recent years. Modern endoscopic strategies including endoscopic resection …

The new developments in the management of Barrett's esophagus in 2005 result in
refinements of decision making. New techniques including magnification endoscopy have …

Barrett's esophagus (BE) is a well-known premalignant condition that can be associated with
the development of dysplasia and adenocarcinoma. In the past, esophagectomy was the …

Esophagectomy has been the traditional therapy for high-grade dysplasia and intramucosal
cancer. Though surgery can completely resect the cancer and the affected lymph nodes, it …

Barrett's esophagus with high-grade dysplasia is a well-known risk factor for the
development of esophageal adenocarcinoma, which has become the predominant form of …

The annual incidence of adenocarcinoma arising from Barrett's esophagus (BE) is
approximately 0.5%. Through a process of gradual transformation from low-grade dysplasia …

In Barrett's esophagus, the stratified squamous epithelium lining the esophagus is replaced
by specialized intestinal-type columnar epithelium. The prevalence of Barrett's esophagus …